Concepedia

Publication | Open Access

<p>LncRNA HEIH Confers Cell Sorafenib Resistance in Hepatocellular Carcinoma by Regulating miR-98-5p/PI3K/AKT Pathway</p>

DOIFull Paper Access

39

Citations

23

References

2020

Year

Qian Shen, Shenhua Jiang, Mingyun Wu, Lei Zhang, Xue Su, Ding Zhao
Cancer Management and Research

Abstract

HEIH conferred an advantage to sorafenib resistance in HCC by the activation of PI3K/AKT pathway through miR-98-5p, indicating a potential therapeutic strategy for HCC chemotherapy.

References

YearCitations

Page 1